ReachMD

Popular

• • 

    

    Joel L. Cohen, MD

    Peer

  • 

    

    Carolyn I. Jacob, MD, FAAD

    Peer

  10

  

  RestartResume

  Neuromodulator Dosing for Duration

  Neuromodulator Dosing for Duration

  0.25 credits

• • 

    

    Gerard A. Silvestri MD, MS, FCCP

    Peer

  • 

    

    Lonny Brett Yarmus, DO, FCCP

    Peer

  0

  

  RestartResume

  Exploring the Pulmonologist’s Role: Managing Early-Stage Lung Cancer

  Exploring the Pulmonologist’s Role: Managing Early-Stage Lung Cancer

• • 

    

    Gerard A. Silvestri MD, MS, FCCP

    Peer

  • 

    

    Catherine R. Sears, MD

    Peer

  1

  

  RestartResume

  Coordination & Collaboration: Implementing a Multidisciplinary Lung Cancer Program

  Coordination & Collaboration: Implementing a Multidisciplinary Lung Cancer Program

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Andrew M. Kaunitz, MD, FACOG

    Peer

  18

  

  RestartResume

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  0.25 credits

• • 

    

    Patricia K. Coyle, MD

    Peer

  • 

    

    Mitzi Joi Williams, MD

    Peer

  4

  

  RestartResume

  Patient-Centric Considerations for Therapeutic Decisions in Multiple Sclerosis

  Patient-Centric Considerations for Therapeutic Decisions in Multiple Sclerosis

  0.25 credits

• • 

    

    Patricia K. Coyle, MD

    Peer

  • 

    

    Jiwon Oh, MD

    Peer

  2

  

  RestartResume

  Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis

  Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis

  0.25 credits

• • 

    

    Shannon L. Meeks, MD

    Peer

  • 

    

    Cindy Leissinger, MD

    Peer

  2

  

  RestartResume

  What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment

  What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment

  0.25 credits

• • 

    

    Shannon L. Meeks, MD

    Peer

  • 

    

    Jonathan C. Roberts, MD

    Peer

  2

  

  RestartResume

  Practical Guidance for Surveillance and Reporting in Hemophilia A

  Practical Guidance for Surveillance and Reporting in Hemophilia A

  0.25 credits

• • 

    

    Neilanjan Nandi, MD

    Peer

  • 

    

    Miguel Regueiro, MD, AGAF

    Peer

  4

  

  RestartResume

  Goals of Managing IBD – Treating to Target

  Goals of Managing IBD – Treating to Target

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Barbara Dehn

    Peer

  8

  

  RestartResume

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  0.25 credits

• • 

    

    Emily Chew, MD

    Peer

  • 

    

    Neil Bressler, MD

    Peer

  • 

    

    Joseph M. Coney, MD

    Peer

  • 

    

    Steven Ferrucci, OD, FAAO

    Peer

  2

  

  RestartResume

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  0.25 credits

• • 

    

    Neilanjan Nandi, MD

    Peer

  • 

    

    Russell D. Cohen, MD, FACG, AGAF

    Peer

  2

  

  RestartResume

  New Viewpoints in the Management of IBD

  New Viewpoints in the Management of IBD

  0.25 credits

• • 

    

    Diana Shechtman, OD, FAAO

    Peer

  • 

    

    Mark T. Dunbar, OD, FAAO

    Peer

  2

  

  RestartResume

  Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO

  Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO

  0.25 credits

• • 

    

    Diana V. Do, MD

    Peer

  • 

    

    Julia Haller, MD

    Peer

  • 

    

    Rishi P. Singh, MD

    Peer

  1

  

  RestartResume

  Optimizing Vision Outcomes in nAMD

  Optimizing Vision Outcomes in nAMD

  0.25 credits

• • 

    

    Floor J. Backes, MD

    Peer

  • 

    

    Robert L. Coleman, MD, FACOG, FACS

    Peer

  4

  

  RestartResume

  Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

  Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

  0.25 credits